Evidence for involvement of NF-kappa B in the transcriptional control of COX-2 gene expression by IL-1 beta

被引:353
作者
Newton, R
Kuitert, LME
Bergmann, M
Adcock, IM
Barnes, PJ
机构
[1] Department of Thoracic Medicine, National Heart and Lung Institute, Imperial College School of Medicine, London, SW3 6LY, Dovehouse Street
关键词
D O I
10.1006/bbrc.1997.7064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cycloxygenase (COX) isoforms COX-1 and COX-2 convert arachidonic acid to prostaglandin (PG) precursors and are a limiting step in PG production, Interleukin-1 beta (IL-1 beta) treatment of type II A549 cells increases PGE(2) synthesis via transcription-and translation-dependent induction of COX-2. IL-1 beta produces a 10-fold induction of COX-2 mRNA and an 8-fold increase in COX-2 transcription that was temporally preceded by activation of the transcription factor nuclear facter-kappa B (NF-kappa B). The protein-tyrosine phosphatase inhibitor phenylarsine oxide (PAO) prevented both NF-kappa B activation and induction of COX-2 mRNA. We show that two putative NF-kappa B motifs, kappa Bu (-447/-438) and kappa Bd (-224/-214), from the COX-2 promoter bind p50/p65 NF-kappa B heterodimers in an IL-1 beta-dependent manner and that the upstream element has the greater affinity. Finally, we demonstrate that the two NF-kappa B subunits, p50 and p65, synergistically activate a -917/+49 COX-2 promoter construct, We conclude that IL-1 beta stimulates PG production via transcriptional activation of COX-2 and provide evidence that this may involve NF-kappa B. (C) 1997 Academic Press.
引用
收藏
页码:28 / 32
页数:5
相关论文
共 26 条
[1]   STRUCTURE OF THE HUMAN CYCLO-OXYGENASE-2 GENE [J].
APPLEBY, SB ;
RISTIMAKI, A ;
NEILSON, K ;
NARKO, K ;
HLA, T .
BIOCHEMICAL JOURNAL, 1994, 302 :723-727
[2]   AIRWAY EPITHELIAL-CELLS AND MEDIATORS OF INFLAMMATION [J].
DEVALIA, JL ;
DAVIES, RJ .
RESPIRATORY MEDICINE, 1993, 87 (06) :405-408
[3]   Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: Initial analysis of the human NOS2 promoter [J].
deVera, ME ;
Shapiro, RA ;
Nussler, AK ;
Mudgett, JS ;
Simmons, RL ;
Morris, SM ;
Billiar, TR ;
Geller, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (03) :1054-1059
[4]  
FLETCHER BS, 1992, J BIOL CHEM, V267, P4338
[5]  
HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.bi.60.070191.001433
[6]   HUMAN CYCLOOXYGENASE-2 CDNA [J].
HLA, T ;
NEILSON, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7384-7388
[7]   TRANSCRIPTIONAL REGULATION OF HUMAN PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE-2 GENE BY LIPOPOLYSACCHARIDE AND PHORBOL ESTER IN VASCULAR ENDOTHELIAL-CELLS - INVOLVEMENT OF BOTH NUCLEAR FACTOR FOR INTERLEUKIN-6 EXPRESSION SITE AND CAMP RESPONSE ELEMENT [J].
INOUE, H ;
YOKOYAMA, C ;
HARA, S ;
TONE, Y ;
TANABE, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (42) :24965-24971
[8]   CHARACTERIZATION OF THE HUMAN GENE (PTGS2) ENCODING PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE-2 [J].
KOSAKA, T ;
MIYATA, A ;
IHARA, H ;
HARA, S ;
SUGIMOTO, T ;
TAKEDA, O ;
TAKAHASHI, E ;
TANABE, T .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 221 (03) :889-897
[9]   SELECTIVE-INHIBITION OF INDUCIBLE CYCLOOXYGENASE-2 IN-VIVO IS ANTIINFLAMMATORY AND NONULCEROGENIC [J].
MASFERRER, JL ;
ZWEIFEL, BS ;
MANNING, PT ;
HAUSER, SD ;
LEAHY, KM ;
SMITH, WG ;
ISAKSON, PC ;
SEIBERT, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3228-3232
[10]   CYCLOOXYGENASE-2 - REGULATION AND RELEVANCE IN INFLAMMATION [J].
MITCHELL, JA ;
LARKIN, S ;
WILLIAMS, TJ .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (10) :1535-1542